New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the ...

A new antibody‑drug conjugate nearly doubles survival and extends overall survival in advanced triple‑negative breast cancer, ...

A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how ...

Clinical trials at Emory and Piedmont are signaling a potential breakthrough in treating pancreatic cancer, one of the nation ...

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

The drug daraxonrasib nearly doubled the overall survival rates of pancreatic cancer patients. Here's how it works and who ...

In a rare move, nonprofit organization Blood Cancer United is buying the remaining supplies of a discontinued investigational ...

By Julie Steenhuysen CHICAGO, May 31 (Reuters) - Revolution Medicine's experimental pancreatic cancer pill doubled survival ...

The Alliance for Clinical Trials in Oncology (Alliance) today announced that the U.S. Food and Drug Administration has ...

By Rishika Sadam June 12 (Reuters) - India's drug price regulator raised ceiling rates for two key platinum-based cancer drugs by 50% after a surge in raw material costs triggered widespread shortages ...